Zhai, Feng-Xian <br/><br/>
RUNX3 is involved in caspase-3-dependent apoptosis induced by a combination of 5-aza-CdR and TSA in leukaemia cell lines.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  Mar 2012 
 - 439-49 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-1335 
<br/><br/><label>Standard No.: </label>10.1007/s00432-011-1113-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Azacitidine--administration & dosage<br/>Blotting, Western<br/>Caspase 3--metabolism<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Core Binding Factor Alpha 3 Subunit--metabolism<br/>CpG Islands<br/>Fluorescent Antibody Technique<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Hydroxamic Acids--administration & dosage<br/>K562 Cells<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Up-Regulation